MANAGEMENT OF THYROID METASTASES: EXPERIENCE OF FIVE REFERRAL CENTRES

AUTHORS:
P.V. Sartori (Desio, Italy) , S. Andreani (Milano, Italy) , L. De Pasquale (Milano, Italy) , R. Melcarne (Roma, Italy) , J. Pauna (Milano, Italy) , F. Prioli (Roma, Italy) , L. Giacomelli (Roma, Italy) , M. Boniardi (Milano, Italy) , M. Raffaelli (Roma, Italy) , M. Iacobone (Padova, Italy)
Background:
Intrathyroid metastases (ITM) in literature are considered rare and with a dismal prognosis. The aim of this study is to detect which neoplasms metastasize most often to the thyroid gland, their clinical features, and treatment options.
Methods:
Retrospective analysis of clinical files of patients submitted to surgery for thyroid disease over 16 years at 5 tertiary referral centers. 18 patients (median age 67,7 years) were affected by ITM.
Results:
The site of the primary tumor was: kidney (15), lung (2), melanoma (1). The mean delay from the primary tumor was 127+/-18 months. Seven patients (40%) complained of preoperative symptoms, in the others, thyroid involvement was incidentally discovered during the follow-up for the primary cancer. 12 patients (67%) underwent total thyroidectomy, 6 thyroid lobectomy. Morbidity was 28% (3 recurrent nerve palsies with 2 nerves involved by tumor, and 2 transient hypoparathyroidism) mortality was nil. The median follow-up was 23 months and 5 year overall survival after thyroid surgery was 90%.
Conclusions:
Even if thyroid metastases are rare, we recommend thyroid imaging be included in the follow-up of tumors known to be prone to metastasize to the thyroid. Fine-needle agobiopsy (FNAB) with immunohistochemical stains may help in preoperative workup. A long delay between the primary tumor and the recurrence warrants surgery since long survival can be achieved. Due to the high complication rate, these patients should be referred to high-volume centers